PNTG
The Pennant Group, Inc.29.73
+0.00+0%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
FY Q4 '25
Conservative guide details integration noise
Q&A framed 2026 guidance as conservative due to Amedisys/UnitedHealth integration noise across first three quarters, mirroring Signature's playbook but on larger scale with multi-wave transitions and TSA costs. Management baked in ~7% same-store home health/hospice revenue growth, slight EBITDA margin expansion despite 1.3% home health rate cut, senior living 100bps occupancy gain and 6% RevPOR lift, G&A at 6.4-6.5% of revenue. Independents gain edge over payer captives in negotiations and consolidated Southeast share. JVs enhance, don't displace, local model. Choppy start expected from transitions. Bullish on year-end optimization toward 15-16% margins.
Key Stats
Market Cap
1.03BP/E (TTM)
39.64Basic EPS (TTM)
0.75Dividend Yield
0%Recent Filings
10-K
FY2025 results
Pennant crushed FY2025 with revenue soaring 36% to $948M, propelled by a blockbuster Q4 acquisition of 21 home health, 5 hospice, and 4 home care agencies from UnitedHealth/Amedisys in new markets Alabama, Georgia, and Tennessee—its largest deal ever. Home health/hospice revenue jumped 41% to $733M on 44% more admissions and 29% higher hospice census, while senior living grew 22% to $215M amid 8% rate hikes and 80bps occupancy gains to 79.7%. Q4 momentum accelerated via 30-agency southeastern push, lifting segment adjusted EBITDAR 38% to $181M despite wage pressures crimping margins slightly. Balance sheet strengthened with $17M cash, $172M revolver capacity post-$100M term loan and equity raise. No dividends or buybacks. Hospice cap risks loom large.
8-K
Pennant smashes 2025 records
Pennant crushed 2025 with revenue soaring 36.3% to $947.7M, driven by 41.0% home health/hospice growth and 22.3% senior living gains; Q4 revenue jumped 53.2% to $289.3M. Home health admissions rocketed 44.1%, hospice census 28.6%. Guidance eyes 2026 revenue at $1.13B-$1.17B. Integration risks loom post-acquisitions.
10-Q
Q3 FY2025 results
Pennant drove Q3 revenue to $229M, up 26.8% y/y from $181M, fueled by home health/hospice growth to $174M (27.9% y/y) and senior living to $55M (23.2% y/y) via nine agencies and four communities added YTD. Operating income slipped to $10M from $11M y/y while margins held at 4.4%, diluted EPS $0.17 (anti-dilution flagged). Cash fell to $2M amid $65M acquisitions, offset by $27M operating cash; revolver shows $26M drawn, $220M available. Acquisitions piled on $32M goodwill. Medicare audits loom large.
8-K
Q3 revenue jumps 27%
Pennant crushed Q3 with $229M revenue, up 26.8% year-over-year, fueled by 36% home health admissions surge and 17% hospice census growth; net income held steady at $6.1M while adjusted EPS hit $0.30. Completed massive October 1 acquisition of 54 agencies from UnitedHealth and Amedisys, its largest ever, expanding Southeast footprint. Raised 2025 guidance to $911M-$949M revenue. Transition risks loom in Q4.
8-K
Pennant adds $100M term loan
Pennant Group secured a $100 million incremental term loan A on November 3, 2025, matching its revolver's rate and July 31, 2029 maturity. Proceeds refinanced revolver draws and covered amendment fees. Lenders include Truist ($30M), Citibank ($22M), RBC ($16M), Regions ($16M), and Wells Fargo ($16M). Standard covenants apply.
IPO
Website
Employees
Sector
Industry
AVAH
Aveanna Healthcare Holdings Inc
8.84-0.05
BKD
Brookdale Senior Living Inc.
10.49+0.19
EHAB
Enhabit, Inc.
9.61-0.08
ENSG
The Ensign Group, Inc.
175.36-1.73
HCA
HCA Healthcare, Inc.
469.79-7.19
HCSG
Healthcare Services Group, Inc.
19.09-0.27
INNV
InnovAge Holding Corp.
5.55-0.27
NHC
National HealthCare Corporation
138.93-0.94
PACS
PACS Group, Inc.
34.20-0.55
SNDA
Sonida Senior Living, Inc.
31.53-0.06